AIM2 was originally discovered to be a tumor suppressor gene in human melanomas [192], and reduced AIM2 expression was associated with poor prognosis in patients and AIM2 mutations in human colorectal tumors [193–195]. The gene discussed is AIM2; the disease is melanoma.